News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
8,010 Results
Type
Article (725)
Company Profile (3)
Press Release (7282)
Section
Business (2124)
Career Advice (30)
Deals (432)
Drug Delivery (2)
Drug Development (925)
Employer Resources (3)
FDA (127)
Job Trends (272)
News (3535)
Policy (325)
Tag
Academia (48)
Alliances (549)
ALS (6)
Alzheimer's disease (27)
Antibody-drug conjugate (ADC) (4)
Approvals (125)
Artificial intelligence (10)
Autoimmune disease (2)
Bankruptcy (3)
Best Places to Work (236)
Biosimilars (3)
Biotechnology (1)
Bladder cancer (2)
Breast cancer (4)
Cancer (49)
Cardiovascular disease (19)
Career advice (24)
Career pathing (1)
CAR-T (5)
CDC (1)
Cell therapy (13)
Clinical research (782)
Collaboration (21)
Compensation (1)
COVID-19 (35)
CRISPR (2)
C-suite (21)
Cystic fibrosis (2)
Data (86)
Denatured (1)
Depression (4)
Diabetes (5)
Diagnostics (65)
Digital health (1)
Diversity, equity & inclusion (2)
Drug discovery (4)
Drug pricing (2)
Drug shortages (1)
Duchenne muscular dystrophy (6)
Earnings (831)
Editorial (1)
Employer resources (3)
Events (1120)
Executive appointments (16)
FDA (162)
Funding (30)
Gene editing (3)
Generative AI (1)
Gene therapy (20)
GLP-1 (27)
Government (60)
Guidances (7)
Healthcare (182)
HIV (1)
Huntington's disease (3)
IgA nephropathy (1)
Immunology and inflammation (8)
Immuno-oncology (1)
Infectious disease (36)
Inflammatory bowel disease (1)
Inflation Reduction Act (2)
Interviews (3)
IPO (182)
IRA (3)
Job creations (48)
Job search strategy (20)
JPM (2)
Layoffs (14)
Leadership (1)
Legal (69)
Lung cancer (11)
Machine learning (1)
Management (1)
Manufacturing (16)
MASH (3)
Medical device (147)
Medtech (147)
Mergers & acquisitions (259)
Metabolic disorders (18)
Multiple sclerosis (1)
Neurodegenerative disease (3)
Neuroscience (70)
NextGen: Class of 2026 (84)
Non-profit (55)
Obesity (9)
Opinion (13)
Ovarian cancer (1)
Pain (1)
Pancreatic cancer (1)
Parkinson's disease (19)
Partnered (1)
Patents (4)
Patient recruitment (7)
People (723)
Pharmaceutical (1)
Phase 1 (215)
Phase 2 (351)
Phase 3 (322)
Pipeline (95)
Policy (4)
Postmarket research (30)
Preclinical (91)
Press Release (1)
Prostate cancer (1)
Psychedelics (1)
Radiopharmaceuticals (3)
Rare diseases (17)
Real estate (56)
Regulatory (269)
Reports (1)
Research institute (42)
Resumes & cover letters (4)
RNA editing (1)
Schizophrenia (3)
Series A (6)
Series B (2)
Sickle cell disease (1)
Special edition (1)
Spinal muscular atrophy (1)
Startups (40)
Supply chain (4)
Tariffs (5)
The Weekly (1)
Vaccines (37)
Venture capital (3)
Weight loss (6)
Women's health (1)
Date
Last 7 days (12)
Last 30 days (31)
Last 365 days (412)
2026 (45)
2025 (421)
2024 (476)
2023 (626)
2022 (790)
2021 (716)
2020 (915)
2019 (669)
2018 (476)
2017 (402)
2016 (373)
2015 (452)
2014 (255)
2013 (188)
2012 (208)
2011 (178)
2010 (153)
Location
Africa (18)
Arizona (2)
Asia (428)
Australia (89)
California (145)
Canada (32)
China (8)
Colorado (2)
Connecticut (5)
Europe (1889)
Florida (7)
Georgia (1)
Idaho (2)
Illinois (17)
India (2)
Indiana (3)
Japan (7)
Maine (2)
Maryland (44)
Massachusetts (94)
Michigan (2)
Minnesota (5)
Missouri (2)
Nebraska (1)
Nevada (2)
New Jersey (36)
New York (24)
North Carolina (12)
Northern California (50)
Ohio (2)
Pennsylvania (12)
South America (25)
Southern California (75)
Tennessee (1)
Texas (12)
United States (441)
Virginia (3)
Washington D.C. (1)
Washington State (17)
Wyoming (1)
8,010 Results for "horizon therapeutics.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pelthos Therapeutics Secures Up to $50 Million Senior Secured Term Loan Facility from Horizon Technology Finance
January 14, 2026
·
7 min read
Press Releases
SL BIO Ltd. and Horizon Space Acquisition II Corp. Announce Registration Statement Effectiveness and Extraordinary General Meeting Date to Approve Business Combination
January 15, 2026
·
8 min read
Press Releases
Humacyte Announces Six Presentations Scheduled for the Upcoming 52nd Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (VEITHsymposium)
November 14, 2025
·
6 min read
Insights
Programmable RNA 2.0: Beyond the First mRNA Revolution
In this episode of Denatured, Jennifer C. Smith-Parker speaks to Erik Digman Wiklund, CEO of Circio and Jacob Becraft, Co-founder and CEO of Strand Therapeutics. They discuss how post-COVID, emerging platforms like circular and logic circuit RNA are expanding the field’s therapeutic horizons.
February 5, 2026
·
1 min read
·
Jennifer Smith-Parker
Press Releases
LPOXY Initiates $28M Series A Financing with 5 Horizons Ventures to Fund STOP-Cdiff Pivotal Trial
September 3, 2025
·
3 min read
Insights
New UK/EU Rules and AI Adoption Define CRO Priorities for 2026
With new UK clinical trial rules landing in 2026, the EU Biotech Act on the horizon and China and Australia gaining ground, CROs are zeroing in on study timelines, AI/ML and data privacy as the industry’s next pressure points.
December 3, 2025
·
4 min read
·
Jennifer Smith-Parker
Spinal muscular atrophy
6 Therapies on the Horizon for Spinal Muscular Atrophy
Since 2016, the FDA has approved three disease-modifying treatments for spinal muscular atrophy, with several companies—including Novartis, Scholar Rock and Biogen—progressing novel candidates through clinical trials.
March 24, 2025
·
5 min read
·
Natalia Mesa
Press Releases
Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference
April 2, 2025
·
1 min read
Press Releases
Marker Therapeutics to Present at Canaccord Genuity’s Horizons in Oncology Conference
April 1, 2025
·
1 min read
Press Releases
Delcath Systems to Participate at the Canaccord Genuity Horizons in Oncology Virtual Conference
March 24, 2025
·
2 min read
1 of 801
Next
